Outpost Bio raises $3.5M pre-seed to build AI-driven human microbiology models for pharma, food and consumer product R&D.
Outpost Bio is developing AI-driven models to decode human microbiology by combining automated experiments with machine learning, aiming to help pharma, food, and consumer companies design safer and ...
Forbes contributors publish independent expert analyses and insights. David Henkin helps organizations and individuals innovate and grow. Predictive analytics has evolved from a niche discipline into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results